|Articles|May 1, 2001
- Pharmaceutical Executive-05-01-2001
- Volume 0
- Issue 0
Friends of Complexity
Author(s)Wayne Koberstein
Pharmaceutical executives should study their own scientists. They construct clever tools to explore convoluted phenomena. They are the true friends of complexity.
Advertisement
Articles in this issue
about 25 years ago
Policy: Task Mastersabout 25 years ago
Pharmacia's Carrie Cox: HBA Woman of the Yearabout 25 years ago
Under Federal Fireabout 25 years ago
Task Force: Enter the Fixersabout 25 years ago
The Next Y2Kabout 25 years ago
Political ScienceAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Eli Lilly to Acquire AtaiBeckley for $2.8 Billion
3
Pharmaceutical Executive Daily: FDA Approves Lipfendra
4
The Power of Better Questions: How Great Leaders Balance Risk, Growth and Curiosity
5